Shake-up at Icebreaker: US parent company VF Corporation puts retailer through restructure
6 May, 2021 12:30 AM
3 minutes to read
Icebreaker has plans to double the size of its business over the next four years. Photo / Heart of the City
Icebreaker has plans to double the size of its business over the next four years. Photo / Heart of the City
Aimee Shaw is a business reporter focusing on retail, small businessaimee.shaw@nzherald.co.nz@AceeyShaw
VF Corporation-owned merino wool clothing company Icebreaker is undergoing a major restructure, with up to 50 local staff set to lose their jobs. The Ponsonby-based retailer, which operates 16 shops in New Zealand, six in
Northern European integrated drug development consultancy aims to further expand service offering and geographical footprintUTRECHT, the Netherlands and COPENHAGEN, Denmark, May 06, 2021 (GLOBE NEWSWIRE)
Date Time
Nyrada announces to new cholesterol-lowering drug candidates
Australian preclinical drug development company Nyrada (ASX:NYR) has provided an update on the progress of its small molecule cholesterol-lowering program.
The company said a previous in vivo preclinical study showed NYX-PCSK9i reduced total cholesterol by 57 per cent without adverse side effects. It said it has now commenced a new in vivo efficacy study in the same specialised transgenic mouse model to evaluate NYX-PCSK9i in combination with a statin.
Nyrada said the study aims to determine if NYX-PCSK9i enhances the efficacy of a statin when co-administered.
It also said recent medicinal chemistry work has revealed two promising drug candidates (NYX-PCSK9i-211 and NYX-PCSK9i-212) with in vitro testing confirming they have improved potency and bioavailability compared to NYX-PCSK9i.
Proof-of-concept immuno-oncology collaboration with AstraZeneca to build understanding of prostate cancer Alchemab's advanced analytics to be used to analyse patient immune responses, identify